Genmab is an international biotechnology company specializing in the creation and development of differentiated human antibody therapeutics for the treatment of cancer.

Second Quarter 2015 Financial Results

Genmab published its Second Quarter 2015 financial results and held an investor conference call on August 11. Click the following links to access the archived call: Listen to the webcast; download the podcastdownload the slide presentation.

news email 150x110

Get the Latest Genmab News

Subscribe to our email alert mailing list to ensure you receive the latest news from Genmab as it happens. Visit and fill out the form to subscribe.

Our Technologies Explained

Learn about Genmab’s proprietary cutting edge technologies, the DuoBody® and HexaBody® platforms at our new technology website